JPMorgan Chase & Co. Increases Stock Position in Anika Therapeutics, Inc. (NASDAQ:ANIK)
JPMorgan Chase & Co. lifted its holdings in Anika Therapeutics, Inc. (NASDAQ:ANIK – Free Report) by 431.9% during the fourth quarter, Holdings Channel reports. The institutional investor owned 82,491 shares of the biotechnology company’s stock after acquiring an additional 66,982 shares during the quarter. JPMorgan Chase & Co.’s holdings in Anika Therapeutics were worth $1,358,000 […]
JPMorgan Chase & Co. lifted its holdings in Anika Therapeutics, Inc. (NASDAQ:ANIK – Free Report) by 431.9% during the fourth quarter, Holdings Channel reports. The institutional investor owned 82,491 shares of the biotechnology company’s stock after acquiring an additional 66,982 shares during the quarter. JPMorgan Chase & Co.’s holdings in Anika Therapeutics were worth $1,358,000 […]
